Literature DB >> 11306383

Symptoms and quality of life versus age, prostate volume, and urodynamic parameters in 565 strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

M D Eckhardt1, G E van Venrooij, T A Boon.   

Abstract

OBJECTIVES: To investigate the associations of symptoms and quality of life with age, prostate volume, and urodynamic parameters in a large group of strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
METHODS: The 565 consecutive men met all the criteria of the International Consensus Committee on benign prostatic hyperplasia and voided more than 150 mL during uroflowmetry. The residual volumes and prostate sizes were estimated. The International Prostate Symptom Score (IPSS) and quality-of-life score were collected and urodynamic evaluations performed.
RESULTS: The prostate volume and obstruction grade were not, but low detrusor contractility and low bladder capacity were, significantly associated with symptoms. Except for nocturia, older men presented with lower voiding scores on the IPSS. The presence of a residual urine volume hardly influenced patients' symptoms and quality of life. Men with an unstable bladder scored higher on frequency, urgency, and nocturia on the IPSS, but the symptom index and quality-of-life score were not affected by the presence of an unstable bladder. Because of the high variability and subjective interpretation of symptoms and because urodynamic parameters may have opposite implications than symptoms and vice versa, associations were still weak.
CONCLUSIONS: Except for nocturia, older men had lower voiding scores on the IPSS. Prostate volume and obstruction grade were not, but low detrusor contractility and low capacities were, associated with the symptom index. The presence of an unstable bladder and/or residual volume was hardly associated with the symptom index or quality-of-life score. Although we used a large group of strictly selected men, the associations were still weak.

Entities:  

Mesh:

Year:  2001        PMID: 11306383     DOI: 10.1016/s0090-4295(00)01101-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  21 in total

1.  Medical therapy for benign prostatic hyperplasia: new terminology, new concepts, better choices.

Authors:  Steven A Kaplan
Journal:  Rev Urol       Date:  2006

Review 2.  Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH).

Authors:  S Ventura; V l Oliver; C W White; J H Xie; J M Haynes; B Exintaris
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

3.  Correlation of Prostate Gland Size and Uroflowmetry in Patients with Lower Urinary Tract Symptoms.

Authors:  Deepak Sundaram; Ponnusamy Kasirajan Sankaran; Gunapriya Raghunath; S Vijayalakshmi; J Vijayakumar; Maria Francis Yuvaraj; Munnusamy Kumaresan; Zareena Begum
Journal:  J Clin Diagn Res       Date:  2017-05-01

4.  Validation of a Visual Prostate Symptom Score in Men With Lower Urinary Tract Symptoms in a Health Safety Net Hospital.

Authors:  Rachel E Selekman; Catherine R Harris; Pauline Filippou; Thomas Chi; Amjad Alwaal; Sarah D Blaschko; Benjamin N Breyer
Journal:  Urology       Date:  2015-07-10       Impact factor: 2.649

5.  Lower urinary tract symptoms, prostate volume, uroflowmetry, residual urine volume and bladder wall thickness in Turkish men: a comparative analysis.

Authors:  Levent Işikay; K Turgay Akgül; Bariş Nuhoğlu; Gürhan Ozdemir; Ali Ayyildiz; Taner Cavumirza; Cankon Germiyanoğlu
Journal:  Int Urol Nephrol       Date:  2007-03-02       Impact factor: 2.370

6.  Comparative Analysis of Outcomes after Transurethral Resection of the Prostate according to Prostate Shape Shown by Transrectal Ultrasonography.

Authors:  Hyo Serk Lee; Sung Jin Kim; Jae Mann Song; Kwang Jin Kim; Hyun Chul Chung
Journal:  Korean J Urol       Date:  2010-07-20

7.  Changes in nocturia after photoselective vaporization of the prostate for patients with benign prostatic hyperplasia.

Authors:  Chang Ju Lee; Min Chul Cho; Ja Hyeon Ku; Soo Woong Kim; Jae-Seung Paick
Journal:  Korean J Urol       Date:  2010-08-18

8.  The alpha1A-adrenoceptor gene is required for the alpha1L-adrenoceptor-mediated response in isolated preparations of the mouse prostate.

Authors:  Kt Gray; Jl Short; S Ventura
Journal:  Br J Pharmacol       Date:  2008-06-16       Impact factor: 8.739

Review 9.  Overactive bladder and men: indications for anticholinergics.

Authors:  Ricardo R González; Alexis E Te
Journal:  Curr Urol Rep       Date:  2003-12       Impact factor: 3.092

10.  Practical management of nocturia in urology.

Authors:  Myeong Heon Jin; Du Geon Moon
Journal:  Indian J Urol       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.